Analysis of CMV-specific CD4 T cells might help to identify patients at risk of symptomatic CMV infections/reactivations and to decide upon necessity for and duration of antiviral prophylaxis and therapy. The gene discussed is CD4; the disease is cytomegalovirus infection.